Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 781 AL 795

Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis

Martinkova J, Quevenco FC, Karcher H, Ferrari A, Sandset EC, Szoeke C, Hort J, Schmidt R, Chadha AS, Ferretti MT.

JAMA Netw Open. 2021 Sep 1;4(9):e2124124. doi: 10.1001/jamanetworkopen.2021.24124.

Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease

Snider BJ, Holtzman DM.

Neuron. 2021 Oct 20;109(20):3199-3202. doi: 10.1016/j.neuron.2021.08.026. Epub 2021 Aug 24.

Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures

Wang H, Lu J, Zhao X, Qin R, Song K, Xu Y, Zhang J, Chen Y.

Neurol Sci. 2021 Dec;42(12):4913-4920. doi: 10.1007/s10072-021-05616-1. Epub 2021 Sep 22.

Risk of seizures and subclinical epileptiform activity in patients with dementia: A systematic review and meta-analysis

Zhao B, Shen LX, Ou YN, Ma YH, Dong Q, Tan L, Yu JT.

Ageing Res Rev. 2021 Dec;72:101478. doi: 10.1016/j.arr.2021.101478. Epub 2021 Oct 1.

Pathophysiological association between periodontal disease and Alzheimer's disease: Importance of periodontal health in the elderly

Desta NT.

J Oral Biosci. 2021 Dec;63(4):351-359. doi: 10.1016/j.job.2021.08.007. Epub 2021 Oct 9.

Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet

Takeishi J, Tatewaki Y, Nakase T, Takano Y, Tomita N, Yamamoto S, Mutoh T, Taki Y.

Int J Mol Sci. 2021 Nov 15;22(22):12310. doi: 10.3390/ijms222212310.

Environmental Substances Associated with Alzheimer's Disease-A Scoping Review

Elonheimo HM, Andersen HR, Katsonouri A, Tolonen H.

Int J Environ Res Public Health. 2021 Nov 11;18(22):11839. doi: 10.3390/ijerph182211839.

COVID-19 and Alzheimer's Disease: A Literature Review

Hardan L, Filtchev D, Kassem R, Bourgi R, Lukomska-Szymanska M, Tarhini H, Salloum-Yared F, Mancino D, Kharouf N, Haikel Y.

Medicina (Kaunas). 2021 Oct 25;57(11):1159. doi: 10.3390/medicina57111159.

Impressive reddish nodules with neoplastic-like appearance in a patient with Alzheimer's disease

Siragusa M, Lentini M, Schepis C.

Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):300-302. doi: 10.4103/ijdvl.IJDVL_226_19.

Reproducible Evaluation of Diffusion MRI Features for Automatic Classification of Patients with Alzheimer's Disease

Wen J, Samper-González J, Bottani S, Routier A, Burgos N, Jacquemont T, Fontanella S, Durrleman S, Epelbaum S, Bertrand A, Colliot O; Alzheimer’s Disease Neuroimaging Initiative.

Neuroinformatics. 2021 Jan;19(1):57-78. doi: 10.1007/s12021-020-09469-5.

Retinal Microvascular Alterations as the Biomarkers for Alzheimer Disease: Are We There Yet?

Jiang H, Wang J, Levin BE, Baumel BS, Camargo CJ, Signorile JF, Rundek T.

J Neuroophthalmol. 2021 Jun 1;41(2):251-260. doi: 10.1097/WNO.0000000000001140.

Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms

Armstrong GW, Kim LA, Vingopoulos F, Park JY, Garg I, Kasetty M, Silverman RF, Zeng R, Douglas VP, Lopera F, Baena A, Giraldo M, Norton D, Cronin-Golomb A, Arboleda-Velasquez JF, Quiroz YT, Miller JB.

JAMA Ophthalmol. 2021 Jan 1;139(1):49-56. doi: 10.1001/jamaophthalmol.2020.4909.

Stressor-Oriented MUlticomponent Intervention and the WeLl-Being of Patients with Alzheimer's Disease: A Randomized Controlled Trial (SOUL-P)

Yang B, Yang S, Zhang Y, Liu W, Gan Y, Li Y, Jiang D, Luo Y, Zhao Q.

J Alzheimers Dis. 2021;79(1):141-152. doi: 10.3233/JAD-200652.

Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?

Flores-Cuadra JA, Madrid A, Fernández PL, Pérez-Lao AR, Oviedo DC, Britton GB, Carreira MB.

J Alzheimers Dis. 2021;82(s1):S227-S250. doi: 10.3233/JAD-200870.

Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer's disease

Rocha FL, de Vasconcelos Cunha UG, Paschoalin RC, Hara C, Thomaz DP.

Int Clin Psychopharmacol. 2021 Mar 1;36(2):104-105. doi: 10.1097/YIC.0000000000000334.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias